Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange Commission shut the books on a review of Zoll Medical’s sales to Iran, Syria and other countries the U.S. deems “state sponsors of terrorism.”
St. Jude Medical shares gains 2.1% after Goldman Sachs analyst David Roman upgrades his rating on STJ stock and raises his price target by more than 11%.
Boston Scientific’s Lotus transcatheter aortic valve implantation system proves to minimize paravalvular leakage after successful implantation in patients with severe symptomatic aortic stenosis who are too sick to undergo open-heart surgery.